Biobanking has grown tremendously over the years and is currently gaining momentum. The combination of advanced technology, data analytics and automation has transformed traditional biobanks into virtual biobanks, creating transformational Biobanking Market potential. Globally, there are many types of biobanks such as, disease-related biobanks, human-based biobanks quantitatively, tissue banks, blood banks which support the market. The spreading degenerative diseases are benefiting immensely from the growth of this market.
Biobanking Market size was valued at USD 72.0 billion in 2023 and is poised to grow from USD 76.9 billion in 2024 to USD 130.16 billion by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).
The Biobanking Market has grown rapidly in recent years. The integration of advanced technologies into the biobanking process is the main driver for the market. Virtual biobanking is now transforming the biobanking process because it reduces processing time and enables researchers to conduct research more efficiently. Virtual biobanking has helped biobanks generate more revenue, thereby increasing market value and driving Biobanking Market growth. In addition, many software companies are undertaking software developments to facilitate the biobanking process and the adoption of virtual biobanking systems.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/biobanking-market
The 2025 global Biobanking Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Biobanking Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Biobanking Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Biobanking Market is segmented by Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user and region.
Based on Product &Service, the market is segmented into Equipment, Consumables, Services and Software.
Based on Biobanks Type, the market is segmented into Physical/Real Biobanks, Tissue Biobanks, Population Based Biobanks, Genetic (DNA/RNA), Disease Based Biobanks and Virtual Biobanks.
Based on Sample Type, the market is segmented into Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids and Human Waste Products.
Based on Storage Type, the market is segmented into Manual Storage and Automated Storage.
Based on Ownership, the market is segmented into Universities, National/Regional Agencies, Non-Profit Organizations and Private Organizations.
Based on Application, the market is segmented into Regenerative Medicine, Life Science Research and Clinical Research.
Based on End user, the market is segmented into Pharmaceutical, Biotechnology Companies and CROs, Academic, Research Institutes and Hospitals.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Biobanking Market – Regional Analysis:
North America plays an important role in the global biobanking market, driven by advanced healthcare infrastructure, strong research capabilities and an increasing emphasis on innovation in medical research and personalized medicine. North America is hub to many of the world’s leading research institutes, universities, and biopharmaceutical companies. These organizations actively participate in biobanking initiatives to support cutting-edge research in genomics, oncology, and personalized medicine.
Asia-Pacific is expected to exhibit the fastest CAGR during the forecast period. The growth can be attributed to investments in developing countries such as India, China and Japan. These countries have been actively engaged in biobanking market development with several business initiatives to strengthen their market position. For example, in November 2023, AIG Hospital launched its first biobank in the southern region of India. The biobank collected more than 100,000 tissue and blood samples over the next decade. Private biobanks in India are spurring biobanking in the country.
Top Market Players in Biobanking Market are:
Thermo Fisher Scientific Inc. (United States)
Merck KGaA (Germany)
QIAGEN N.V. (Netherlands)
Hamilton Company (United States)
Tecan Trading AG (Switzerland)
Becton, Dickinson and Company (BD) (United States)
Lonza Group AG (Switzerland)
Charles River Laboratories International, Inc. (United States)
BioLife Solutions, Inc. (United States)
Brooks Automation, Inc. (United States)
Greiner Bio-One International GmbH (Austria)
STEMCELL Technologies Inc. (Canada)
Chart Industries, Inc. (United States)
BioIVT (United States)
Firalis S.A. (France)
Celltex Therapeutics Corporation (United States)
Sigma-Aldrich Corporation (United States)
Hope Biosciences (United States)
54Gene (Nigeria)
For a customized report, contact us to request personalization – https://www.skyquestt.com/speak-with-analyst/biobanking-market
Recent Developments:
In July 2023, A revised Swedish Biobank Act was implemented, marking a contemporary update to the existing legislation. While maintaining its core objective of regulating the collection, storage, and ethical usage of identifiable human biological material for approved purposes, the new act addresses and clarifies uncertainties present in the original 2003 law. This modernization aims to enhance the understanding and interpretation of the regulations governing biobanking practices in Sweden.
In June 2023, Denmark, Lithuania, and Switzerland received official confirmation of their membership in the Biobanking and BioMolecular resources Research Infrastructure – European Research Infrastructure Consortium (BBMRI-ERIC). Lithuania and Switzerland transitioned from being Observers to attaining full Membership status, while Denmark has newly joined as an Observer.
Take Action Now: Secure Your Biobanking Market Today – https://www.skyquestt.com/buy-now/biobanking-market
Forward-Looking Insights
The Biobanking Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
